Clinical Trial Results:
Immunogenicity, reactogenicity and safety of the trivalent influenza subunit vaccine Influvac® for the season 2009/2010. An open-label, baseline-controlled multi-center study in two groups: adult subjects ≥18 and ≤60 years and elderly subjects ≥61 years of age.
Summary
|
|
EudraCT number |
2009-010900-27 |
Trial protocol |
DE BE |
Global completion date |
09 Jul 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
11 Jul 2019
|
First version publication date |
11 Jul 2019
|
Other versions |
|
Summary report(s) |
S201.3.128-Synopsis_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.